CAJ | 학술논문

　　目的：探讨自发性气胸胸管内注入设定药物与气胸复发、住院天数及医疗费用的相关性。方法：对60例自发性气胸患者，胸腔闭式引流后X线检查证实肺基本复张后，随机分为对照组（单纯胸腔闭式引流），治疗组（经胸管内注入利多卡因、高渗糖及重组人白介素-2）。随访2~10年。结果：治疗组治愈28例，复发2例，总有效率95%，复发率6%，住院天数平均（10±1）d，住院费用（4000±316）元。对照组患者治愈16例，14例复发，总有效率53%，复发率为46%，住院平均天数为（18±2）d，费用（8000±615）元。两组比较，有效率、复发率、住院天数及住院费用均差异有统计学意义（P<0.01）。结论：利多卡因、高渗糖及重组人白介素-α联合胸腔内注入是治疗及预防复发、减少副作用、缩短住院时间、降低医疗费用的有效方法。
　　목적：탐토자발성기흉흉관내주입설정약물여기흉복발、주원천수급의료비용적상관성。방법：대60례자발성기흉환자，흉강폐식인류후X선검사증실폐기본복장후，수궤분위대조조（단순흉강폐식인류），치료조（경흉관내주입리다잡인、고삼당급중조인백개소-2）。수방2~10년。결과：치료조치유28례，복발2례，총유효솔95%，복발솔6%，주원천수평균（10±1）d，주원비용（4000±316）원。대조조환자치유16례，14례복발，총유효솔53%，복발솔위46%，주원평균천수위（18±2）d，비용（8000±615）원。량조비교，유효솔、복발솔、주원천수급주원비용균차이유통계학의의（P<0.01）。결론：리다잡인、고삼당급중조인백개소-α연합흉강내주입시치료급예방복발、감소부작용、축단주원시간、강저의료비용적유효방법。
Objective:To investigate the relationship between chest tube injected in setting drug and recurrence of pneumothorax,hospital stays,and hospitalization costs in patients with spontaneous pneumothorax. Method:60 patients suffering from spantaneous pneumothorax with chest tube injected were included. After lungs recruitment,60 patients were randomly assigned either a treatment program that included intraluminal injection of Lidocaine heperosmotic glucose and recombinant Human IL-2 or one that only used thoracic close drainage therapy. Follow up for 2-10 years. Result:In the treatment group,the patients who recovered accounted for 95%(28 cases),and relapsed for 6%(2 cases). The mean hospital stay and hospital costs were 10 days,and 4000 yuan,respectively. While in the control group,the cure rates and recurrence rates were 53%(16 cases),and 46%(14 cases),respectively. The mean hospital stay was 18 days,and the hospital cost was 8000 yuan. Conclusion:There was statistically significant effect that using intraluminal injection of Lidocaine,heperosmotic glucose and recombinant Human IL-2 to treatment and prevention of recurrence for the spantaneous pneumothorax,reduce side effects,shorter hospital stays,lower medical costs.